Form 4: Intra-Cellular Therapies Director Exercises Restricted Stock Units
SEC Form 4 Filing
Director Eduardo Rene Salas exercised 1,567 restricted stock units of Intra-Cellular Therapies, Inc. on June 23, 2024.
Summary
- On June 25, 2024, a Form 4 filing was submitted to the SEC regarding Eduardo Rene Salas, a director of Intra-Cellular Therapies, Inc.
- The filing reports a transaction that occurred on June 23, 2024, where Salas exercised 1,567 restricted stock units, each representing a contingent right to receive one share of common stock.
- These restricted stock units vested on June 23, 2024, which was the first anniversary of the grant date.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard equity compensation transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting and exercising of previously granted equity compensation.
Stakeholder Impact
- The exercise of restricted stock units may slightly dilute existing shareholders' equity.
Key Dates
| Date | Description |
|---|---|
| 06/23/2023 | Reporting person was granted 1,567 restricted stock units. |
| 06/23/2024 | Restricted stock units vested and were exercised. |
| 06/25/2024 | Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.